Moderna's Heart Failure mRNA Therapy Raises Concerns
Despite Moderna CEO Stéphane Bancel announcing phase 1 clinical trials for their heart failure mRNA therapy, many remain skeptical about its efficacy and safety due to past issues with other treatments created by the company. With vaccine skepticism already high due to recent reports of adverse reactions and deaths associated with some vaccines, it remains unclear whether or not this new treatment will become widely available in the near future.